JP2011514139A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011514139A5 JP2011514139A5 JP2010523277A JP2010523277A JP2011514139A5 JP 2011514139 A5 JP2011514139 A5 JP 2011514139A5 JP 2010523277 A JP2010523277 A JP 2010523277A JP 2010523277 A JP2010523277 A JP 2010523277A JP 2011514139 A5 JP2011514139 A5 JP 2011514139A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- polyclonal
- cell line
- individual
- rsv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 7
- 238000000034 method Methods 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000012258 culturing Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims 1
- 108091006027 G proteins Proteins 0.000 claims 1
- 102000030782 GTP binding Human genes 0.000 claims 1
- 108091000058 GTP-Binding Proteins 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 238000003491 array Methods 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 230000010354 integration Effects 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 238000001890 transfection Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200701289 | 2007-09-07 | ||
| US97140407P | 2007-09-11 | 2007-09-11 | |
| PCT/DK2008/050218 WO2009030237A2 (en) | 2007-09-07 | 2008-09-04 | Methods for recombinant manufacturing of anti-rsv antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011514139A JP2011514139A (ja) | 2011-05-06 |
| JP2011514139A5 true JP2011514139A5 (enExample) | 2012-11-08 |
Family
ID=40297785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010523277A Pending JP2011514139A (ja) | 2007-09-07 | 2008-09-04 | 抗ｒｓｖ抗体の組み換え製造のための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20090137003A1 (enExample) |
| EP (1) | EP2185590A2 (enExample) |
| JP (1) | JP2011514139A (enExample) |
| KR (1) | KR20100087283A (enExample) |
| CN (1) | CN101821289A (enExample) |
| AU (1) | AU2008295248A1 (enExample) |
| BR (1) | BRPI0817079A2 (enExample) |
| CA (1) | CA2695309A1 (enExample) |
| MX (1) | MX2010002044A (enExample) |
| RU (1) | RU2010113510A (enExample) |
| TW (1) | TW200925279A (enExample) |
| WO (1) | WO2009030237A2 (enExample) |
| ZA (1) | ZA201000756B (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5564249B2 (ja) * | 2006-06-23 | 2014-07-30 | アレシア・バイオセラピューティクス・インコーポレーテッド | 癌に関与するポリヌクレオチド配列およびポリペプチド配列 |
| CA2677771A1 (en) * | 2007-03-01 | 2008-09-04 | Symphogen A/S | Method for cloning cognate antibodies |
| EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| WO2010022738A1 (en) * | 2008-08-29 | 2010-03-04 | Symphogen A/S | Method for cloning avian-derived antibodies |
| WO2010060186A1 (en) | 2008-11-03 | 2010-06-03 | Alethia Biotherapeutics Inc. | Antibodies that specifically block the biological activity of a tumor antigen |
| GB0905023D0 (en) | 2009-03-24 | 2009-05-06 | Univ Erasmus Medical Ct | Binding molecules |
| ES2553440T3 (es) | 2009-08-13 | 2015-12-09 | Crucell Holland B.V. | Anticuerpos contra el virus sincitial respiratorio humano (VSR) y método de uso |
| US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
| CN104628850B (zh) * | 2009-10-06 | 2020-07-28 | 医学免疫有限公司 | Rsv-特异性结合分子 |
| BR112012008173B1 (pt) * | 2009-10-06 | 2021-12-07 | Medimmune Ltd | Anticorpo monoclonal humano recombinante, sintético ou isolado ou uma parte funcional do mesmo que se liga especificamente à proteína f do vírus sincicial respiratório, sequência de ácido nucleico isolada ou um equivalente funcional da mesma, vetor, combinação, composição farmacêutica, usos dos mesmos e método para produzir um anticorpo ou parte funcional do mesmo |
| WO2011072204A1 (en) | 2009-12-10 | 2011-06-16 | Regeneron Pharmaceuticals, Inc. | Mice that make heavy chain antibodies |
| TWI627964B (zh) | 2010-07-09 | 2018-07-01 | 傑森疫苗防護公司 | 抗-人類呼吸道融合性病毒（ｒｓｖ）抗體及其使用方法 |
| JP6294221B2 (ja) | 2011-03-31 | 2018-03-14 | アー・デー・ツェー・セラピューティクス・エス・アー | 腎臓関連抗原１に対する抗体およびその抗原結合性フラグメント |
| TR201908872T4 (tr) | 2012-01-09 | 2019-07-22 | Adc Therapeutics Sa | Üçlü negatif meme kanserini tedavi etmek için ajanlar. |
| TR201900694T4 (tr) * | 2012-08-23 | 2019-02-21 | Agensys Inc | 158p1d7 proteinlerine bağlanan antikor ilaç konjugatları (adc). |
| JP5996707B2 (ja) * | 2015-04-15 | 2016-09-21 | メディミューン リミテド | Ｒｓｖ特異的結合分子 |
| PH12017502013B1 (en) | 2015-05-07 | 2022-07-22 | Agenus Inc | Anti-ox40 antibodies and methods of use thereof |
| EP3383914A4 (en) * | 2015-12-02 | 2019-10-30 | Agenus Inc. | ANTI-OX40 ANTIBODIES AND METHOD OF USE THEREOF |
| CA3006963A1 (en) * | 2015-12-03 | 2017-06-08 | Ludwig Institute For Cancer Research Ltd. | Anti-ox40 antibodies and methods of use thereof |
| SG11201903287PA (en) * | 2016-10-21 | 2019-05-30 | Adimab Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| US11479600B2 (en) | 2016-10-21 | 2022-10-25 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| CA3040893A1 (en) | 2016-10-21 | 2018-04-26 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| EP3538152A4 (en) | 2016-11-09 | 2020-09-30 | Agenus Inc. | ANTI-OX40 ANTIBODIES, ANTI-GITR ANTIBODIES, AND PROCESSES FOR USE |
| WO2018150029A1 (en) * | 2017-02-17 | 2018-08-23 | Institut Pasteur | Generation of monoclonal antibodies targeting respiratory syncytial virus (rsv) using regulatory b cells from newborns (nbregs) |
| WO2021202463A1 (en) | 2020-03-30 | 2021-10-07 | Danisco Us Inc | Anti-rsv antibodies |
| WO2021253002A1 (en) | 2020-06-12 | 2021-12-16 | Gigagen, Inc. | Recombinant polyclonal proteins targeting covid-19 and methods of use thereof |
| WO2022031834A1 (en) | 2020-08-05 | 2022-02-10 | Gigagen, Inc. | Recombinant polyclonal proteins targeting zika and methods of use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060275766A1 (en) * | 2003-01-07 | 2006-12-07 | Haurum John S | Method for manufacturing recombinant polyclonal proteins |
| TWI333977B (en) * | 2003-09-18 | 2010-12-01 | Symphogen As | Method for linking sequences of interest |
| AU2005263334C1 (en) * | 2004-07-20 | 2011-01-20 | Symphogen A/S | A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line |
| KR20070038556A (ko) * | 2004-07-20 | 2007-04-10 | 심포젠 에이/에스 | 항-ｒｈｅｓｕｓ ｄ 재조합 폴리클로날 항체 및 이의 제조방법 |
| US7850965B2 (en) * | 2005-12-05 | 2010-12-14 | Symphogen A/S | Anti-orthopoxvirus recombinant polyclonal antibody |
| CA2638833A1 (en) * | 2006-03-06 | 2007-09-13 | Symphogen A/S | Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections |
| EP2134747A2 (en) * | 2007-03-06 | 2009-12-23 | Symphogen A/S | Recombinant antibodies for treatment of respiratory syncytial virus infections |
| PL2152872T3 (pl) * | 2007-05-25 | 2011-03-31 | Symphogen As | Sposób wytwarzania rekombinowanego białka poliklonalnego |
-
2008
- 2008-09-04 EP EP08784476A patent/EP2185590A2/en not_active Withdrawn
- 2008-09-04 MX MX2010002044A patent/MX2010002044A/es not_active Application Discontinuation
- 2008-09-04 KR KR1020107007563A patent/KR20100087283A/ko not_active Withdrawn
- 2008-09-04 BR BRPI0817079A patent/BRPI0817079A2/pt not_active IP Right Cessation
- 2008-09-04 JP JP2010523277A patent/JP2011514139A/ja active Pending
- 2008-09-04 CN CN200880106131A patent/CN101821289A/zh active Pending
- 2008-09-04 CA CA2695309A patent/CA2695309A1/en not_active Abandoned
- 2008-09-04 AU AU2008295248A patent/AU2008295248A1/en not_active Abandoned
- 2008-09-04 RU RU2010113510/10A patent/RU2010113510A/ru not_active Application Discontinuation
- 2008-09-04 WO PCT/DK2008/050218 patent/WO2009030237A2/en not_active Ceased
- 2008-09-05 US US12/230,885 patent/US20090137003A1/en not_active Abandoned
- 2008-09-05 TW TW097134053A patent/TW200925279A/zh unknown
-
2010
- 2010-02-01 ZA ZA2010/00756A patent/ZA201000756B/en unknown
-
2011
- 2011-09-23 US US13/243,768 patent/US20120009623A1/en not_active Abandoned